← Back to directory

Aristide Merola

Researcher Next ID · RN-021865

Researcher · Medicine

Merck & Co., Inc., Rahway, NJ, USA (United States)

Rahway, Philippines

Not currently recruitingFunding unknown
Works count
215
Citation count
9,596
H-index
50
i10-index
131

Research interests

Medicine
Parkinson's Disease Mechanisms and Treatments
Neurological disorders and treatments
Botulinum Toxin and Related Neurological Disorders
Cardiovascular Syncope and Autonomic Disorders
Parkinson's Disease and Spinal Disorders

Publications

  • Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

    Neurology · 2019 · 10.1212/wnl.0000000000006926

  • A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

    Movement Disorders · 2019 · 10.1002/mds.27671

  • Levodopa‐Induced Neuropathy: A Systematic Review

    Movement Disorders Clinical Practice · 2018 · 10.1002/mdc3.12688

  • Functional neurological disorders in Parkinson disease

    Journal of Neurology Neurosurgery & Psychiatry · 2018 · 10.1136/jnnp-2017-317378

  • Telemedicine in Neurological Disorders: Opportunities and Challenges

    Telemedicine Journal and e-Health · 2018 · 10.1089/tmj.2018.0101

  • Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts

    Annals of Neurology · 2018 · 10.1002/ana.25364

  • Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration

    Annals of Neurology · 2017 · 10.1002/ana.25046

  • A daptive deep brain stimulation controls levodopa‐induced side effects in P arkinsonian patients

    Movement Disorders · 2017 · 10.1002/mds.26953

  • Autonomic dysfunction in Parkinson's disease: A prospective cohort study

    Movement Disorders · 2017 · 10.1002/mds.27268

  • Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trials

    Movement Disorders · 2017 · 10.1002/mds.26913

  • Technology in Parkinson's disease: Challenges and opportunities

    Movement Disorders · 2016 · https://doi.org/10.1002/mds.26642

  • Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets

    The Lancet Neurology · 2016 · 10.1016/s1474-4422(16)30079-5

  • Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?

    Parkinsonism & Related Disorders · 2016 · 10.1016/j.parkreldis.2016.09.013

  • Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease?

    Parkinsonism & Related Disorders · 2014 · https://doi.org/10.1016/j.parkreldis.2014.01.012

  • Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study

    Movement Disorders · 2013 · 10.1002/mds.25585

  • Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease

    Movement Disorders · 2011 · 10.1002/mds.23903

  • Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients

    Brain · 2011 · 10.1093/brain/awr121

  • Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: A 15 months follow-up study

    Brain stimulation · 2011 · 10.1016/j.brs.2011.07.001

  • Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter

    Journal of Neuropathology & Experimental Neurology · 2009 · 10.1097/nen.0b013e3181a19a5a

  • Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study

    Journal of Neuroimmunology · 2008 · 10.1016/j.jneuroim.2008.04.035

  • Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage

    Journal of Neuropathology & Experimental Neurology · 2007 · 10.1097/nen.0b013e31812571b0

  • Intra- and extracellular measurement of reactive oxygen species produced during heat stress in diaphragm muscle

    American Journal of Physiology-Cell Physiology · 2000 · 10.1152/ajpcell.2000.279.4.c1058

  • Antioxidants protect rat diaphragmatic muscle function under hypoxic conditions

    Journal of Applied Physiology · 1998 · 10.1152/jappl.1998.84.6.1960

  • Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin

    Journal of Applied Physiology · 1985 · 10.1152/jappl.1985.59.4.1298

  • Ion Transport by Heart Mitochondria

    Journal of Biological Chemistry · 1970 · 10.1016/s0021-9258(18)62769-3

Current projects

    No projects listed.